Lecture

In this 1h23 lesson, explore which overweight and obese patients may respond well to glucagon-like peptide 1 analogues and which obese patients are candidates for HCG treatment, how to differentiate clinically (symptomatically) obese patients with diencephalon deficiency and how to treat overweight patients with various glucagon-like peptide 1 analogues and adjust doses and type of GLP-1 analogue to the patients.